Amundi Asset Management US’s Q32 Bio QTTB Stock Holding History

Amundi Asset Management US’s Portfolio QTTB Stock Details QTTB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-56	Closed	-$19K	–	1631
2018 Q1	$19K	Buy	+56	New	+$18.8K	﹤0.01%	1513

Other funds holding QTTB

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Amundi Asset Management US's QTTB Position: Q2 2018 in Review

Amundi Asset Management US sold out of Q32 Bio (QTTB) in Q2 2018, closing a stake of 56 shares — an estimated $19K sold.

Amundi Asset Management US first reported a position in QTTB in Q1 2018 and held it in 1 quarter. The position peaked at $19K in Q1 2018. 53 funds tracked by Wall St. Rank hold QTTB as of Q2 2018.

Amundi Asset Management US reported no remaining Q32 Bio position as of Q2 2018 after selling out during the quarter.
Amundi Asset Management US sold 56 Q32 Bio shares in Q2 2018, an estimated $19K.
Amundi Asset Management US first reported a position in Q32 Bio in Q1 2018 and held it in 1 quarter.
Amundi Asset Management US's Q32 Bio position peaked at $19K in Q1 2018.
53 funds tracked by Wall St. Rank held Q32 Bio as of Q2 2018.

Based on Amundi Asset Management US's 13F filing for Q2 2018, filed 13 Aug 2018.